IRIS
FALAGARIO, UGO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.801
EU - Europa 2.670
AS - Asia 2.464
SA - Sud America 507
Continente sconosciuto - Info sul continente non disponibili 504
AF - Africa 77
OC - Oceania 6
Totale 12.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.570
SG - Singapore 1.158
RU - Federazione Russa 660
IT - Italia 462
IE - Irlanda 457
CN - Cina 439
BR - Brasile 398
HK - Hong Kong 308
SE - Svezia 286
DE - Germania 189
FR - Francia 178
VN - Vietnam 166
BD - Bangladesh 119
GB - Regno Unito 105
CA - Canada 103
IN - India 76
FI - Finlandia 71
UA - Ucraina 70
MX - Messico 41
AT - Austria 36
AR - Argentina 30
ID - Indonesia 26
IQ - Iraq 26
TR - Turchia 26
PL - Polonia 25
CZ - Repubblica Ceca 24
ZA - Sudafrica 23
VE - Venezuela 22
NL - Olanda 21
CR - Costa Rica 18
JP - Giappone 17
CO - Colombia 14
GR - Grecia 12
ES - Italia 11
MA - Marocco 11
SA - Arabia Saudita 11
HN - Honduras 10
PE - Perù 10
PY - Paraguay 10
BE - Belgio 9
EC - Ecuador 8
IR - Iran 8
PK - Pakistan 8
AL - Albania 7
CL - Cile 7
DZ - Algeria 7
EG - Egitto 7
GT - Guatemala 7
JM - Giamaica 7
KE - Kenya 7
LT - Lituania 7
NP - Nepal 7
PR - Porto Rico 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
IL - Israele 6
PH - Filippine 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BG - Bulgaria 5
KG - Kirghizistan 5
LB - Libano 5
MY - Malesia 5
UZ - Uzbekistan 5
CH - Svizzera 4
DK - Danimarca 4
GP - Guadalupe 4
JO - Giordania 4
NI - Nicaragua 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CG - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
GD - Grenada 3
HU - Ungheria 3
KH - Cambogia 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
SC - Seychelles 3
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KR - Corea 2
KW - Kuwait 2
KZ - Kazakistan 2
MD - Moldavia 2
PT - Portogallo 2
QA - Qatar 2
Totale 11.510
Salva come PNG Salva come JPEG
Città #
San Jose 1.216
Singapore 580
Dallas 568
Ashburn 484
Dublin 454
Hong Kong 306
Chandler 240
Santa Clara 228
New York 203
Council Bluffs 186
Nyköping 184
Beijing 177
Columbus 153
Lauterbourg 119
Los Angeles 94
North Bergen 86
Munich 81
Moscow 61
Rome 58
Phoenix 54
Helsinki 50
Ho Chi Minh City 48
Princeton 46
São Paulo 43
Jacksonville 40
Milan 35
London 34
Atlanta 31
Hanoi 31
Orem 31
San Francisco 31
Montreal 29
The Dalles 28
Bari 27
Chicago 26
Frankfurt am Main 26
Hudson 26
Nuremberg 26
Pune 26
Brooklyn 25
Seattle 23
Dearborn 21
Turku 20
Denver 19
Düsseldorf 19
Toronto 19
Wilmington 19
Boston 16
Naples 16
Vienna 16
Warsaw 16
Falkenstein 15
San José 15
Baghdad 14
Chennai 14
Shanghai 14
Buffalo 13
Guangzhou 13
Olomouc 13
Assago 12
Belo Horizonte 12
Boardman 12
Des Moines 12
Nanjing 12
Da Nang 11
Johannesburg 11
Mexico City 11
Ottawa 11
Rio de Janeiro 11
Tokyo 11
Brno 10
Manchester 10
Wuhan 10
Bologna 9
Genoa 9
Haiphong 9
Hillsboro 9
Natal 9
Paris 9
Florence 8
Houston 8
Miami 8
Brasília 7
Brussels 7
Guarulhos 7
Marousi 7
Oklahoma City 7
Pescara 7
Philadelphia 7
Queens 7
Washington 7
Catania 6
Dhaka 6
Jiaxing 6
Murrysville 6
Porto Alegre 6
San Salvador 6
Stockholm 6
Tehran 6
Bishkek 5
Totale 6.856
Salva come PNG Salva come JPEG
Nome #
Techniques for Penile Augmentation Surgery: A Systematic Review of Surgical Outcomes, Complications, and Quality of Life 544
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 235
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 224
Evaluation of citrate-based nutraceutical combinations and their impact on chemolysis in the management of urinary diversion device: a randomised double-blind placebo-controlled study on improved quality of life and clinical outcomes 211
Artificial intelligence and radiomics applications in adrenal lesions: a systematic review 199
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 180
Stapled W-shaped (Hautmann) Orthotopic Ileal Neobladder. Functional Results and Complications over a 13-year Period 171
Elderly patients and prostate biopsy. How old is too old? 161
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 159
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 148
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 147
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data 146
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 144
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 139
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 138
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 135
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 128
Advanced ureteroscopic techniques for the management of kidney stones 122
A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques 121
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 121
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series 118
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 118
Male esthetic genital surgery: recommendations and gaps to be filled 116
Evaluation of periodontal indices among non-smokers, tobacco, and e-cigarette smokers: a systematic review and network meta-analysis 115
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators 114
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index 113
Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests 113
Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center 111
Sexual function recovery following open and robotic radical prostatectomy: results of an academic penile rehabilitation program 108
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 106
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease 105
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 104
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 103
Prostate cancer biomarkers: a practical review based on different clinical scenarios 103
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 101
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 100
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 99
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  98
Elderly patients and prostate biopsy. How old is too old? 97
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 97
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 92
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 90
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 90
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 89
Impact of low-intensity extracorporeal shockwave therapy on vascular parameters and sexual function in patients with arteriogenic erectile dysfunction 89
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 88
Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database 86
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 85
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group 85
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? 83
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 82
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? 81
The prostatic inflammation score and risk of biochemical recurrence following radical prostatectomy 80
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer 80
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study 79
Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion 79
ZSI-375 artificial urinary sphincter: efficacy, safety, and long-term outcomes 78
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression 77
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 76
Penoscrotal approach for inflatable penile prosthesis implant: why it should be preferred 76
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy 76
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care 75
A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer 74
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies 74
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role 73
The natural history of untreated muscle-invasive bladder cancer 73
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report 73
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy 72
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 72
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy 72
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy 71
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 70
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 70
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization 69
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy 68
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” 67
Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extension according to nccn risk categories: implication for surgical planning 67
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working Group 67
Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence 66
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysis 66
Acute kidney injury as a predictor of infectious complications after mini-PCNL 66
Mini invasive approaches in the treatment of small renal masses: TC-guided renal cryoablation in elderly 65
Radiomics in prostate cancer: an up-to-date review 64
An original surgical approach to manage complete rectal lumen obliteration following stapled hemorrhoidopexy 63
UroLift to preserve seminal parameters in young male with LUTS from BPH 62
Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer 62
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification 62
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 62
Decipher Score predicts prostate specific antigen persistence after prostatectomy 61
The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature 61
A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection 61
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion 61
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences 60
Robotic-assisted surgery for the treatment of urologic cancers: recent advances 60
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in Males 60
Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies 59
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level 59
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 58
Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer in Clinical Practice-A Comprehensive Review on State-of-the-Art Advances and Critical Issues 57
Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer 56
Totale 10.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022283 0 0 0 11 33 7 26 11 56 62 6 71
2022/20231.211 116 86 37 62 72 97 8 98 534 34 41 26
2023/2024669 40 34 26 13 28 184 133 33 39 37 22 80
2024/20252.160 150 28 59 44 62 238 224 126 592 172 203 262
2025/20264.932 286 500 603 420 289 208 918 491 310 422 223 262
2026/20272.456 151 565 546 1.194 0 0 0 0 0 0 0 0
Totale 12.029